Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Nordic Laboratories Oy
OY
Active
Y-tunnus 2885093-9
Elimäenkatu 15
Diagnostic imaging services and medical laboratory activities · NACE 8691
Est. 2018
— employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2025
EUR 1,5M
-99% vs 2024
EBITDA margin
22.0%
+111% vs 2024
Equity ratio
54.9%
Financial strength
Net profit 2025
EUR 218K
+152% vs 2024
EBITDA — year on year
EUR millions
0M
-0M
-1M
-1M
-1M
0M
2021
0M
0%
2022
0M
0%
2023
0M
0%
2024
0M
0%
2025
Key figures
Annual report 2025
Revenue
EUR 1,5M
-99%
EBITDA
EUR 327K
+111%
Net profit
EUR 218K
+152%
Total assets
EUR 952K
+69%
Equity
EUR 522K
+72%
Employees
—
—
Company information
Legal name
Nordic Laboratories Oy
Y-tunnus number
2885093-9
Legal form
Osakeyhtiö
NACE code
8691 · Diagnostic imaging services and medical laboratory activities
Founded
19. tammikuuta 2018
Share capital
EUR 10 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Company purpose
Laboratoriotutkimukset.
Contact
Address
Elimäenkatu 15
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Diagnostic imaging services and medical laboratory activities
Companies in Helsinki
All Finland companies
Revenue
EUR millions
0M
32M
63M
95M
126M
0M
2021
1M
2022
1M
2023
110M
2024
1M
2025
EBITDA
EUR millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
0M
2025
Income statement
EUR thousands
Item
2021
2022
2023
2024
2025
Revenue
390
535
814
110 002
1 487
Staff expenses
−161
−195
−246
−320
−453
EBITDA
2
36
114
155
327
Depreciation & amort.
−6
−29
−36
−55
−55
EBIT
−4
8
78
100
271
Net financials
−0
0
−1
−0
−8
Profit before tax
−4
8
77
99
263
Tax
3
−0
−0
−0
45
Net profit
−8
8
77
87
218
Balance sheet
EUR thousands
Item
2021
2022
2023
2024
2025
Total assets
64
168
408
564
952
Equity
−135
135
217
304
522
Long-term debt
149
0
0
46
0
Short-term debt
50
34
191
260
430
Total debt
199
34
191
260
430
Financial ratios
5-year trend
EBITDA margin
22.0%
This company
15.8%
Market median
+39% vs market
2021
2025
Equity ratio
54.9%
This company
38.2%
Market median
+44% vs market
2021
2025
Return on equity
41.8%
This company
18.4%
Market median
+127% vs market
2021
2025
Net profit margin
14.7%
This company
8.1%
Market median
+81% vs market
2021
2025
Asset turnover
1.56×
This company
1.12×
Market median
+39% vs market
2021
2025
Debt / equity
0.82×
This company
0.62×
Market median
+32% vs market
2021
2025
Annual reports & filings
Annual report 2025
Filed via PRH / YTJ · Period 2024-07-01 – 2025-06-30
View
PDF
Annual report 2024
Filed via PRH / YTJ · Period 2023-07-01 – 2024-06-30
View
PDF
Annual report 2023
Filed via PRH / YTJ · Period 2022-07-01 – 2023-06-30
View
PDF
Annual report 2022
Filed via PRH / YTJ · Period 2021-07-01 – 2022-06-30
View
PDF
Annual report 2021
Filed via PRH / YTJ · Period 2020-07-01 – 2021-06-30
View
PDF
Management
Actively employed in the business
Name
Role
Member since
Current (2)
AC
Anne Catherine Færgemann Moore
Deputy Member
Deputy Member
2018
CJ
Christopher John Liebe Moore
Chief Executive Officer
Chief Executive Officer
2018
Former (2)
JA
Jose Adam Juhani Kautonen
Deputy auditor
Deputy auditor
2023 – 2025
KK
Kiri Kasperi Sopanen
Audit
Audit
2023 – 2025
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Nordic Laboratories Oy also hold positions in
0
other companies.
Person
Role here
Other companies
Anne Catherine Færgemann Moore
Deputy Member
0 companies
Jose Adam Juhani Kautonen
Deputy auditor
0 companies
Christopher John Liebe Moore
Chief Executive Officer
0 companies
Kiri Kasperi Sopanen
Audit
0 companies